Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy Joseph A. SparanoEtta D. PisanoRobert L. Comis Editorial 19 December 2009 Pages: 273 - 284
Adjuvant therapy of triple negative breast cancer Edith A. PerezAlvaro Moreno-AspitiaCathy A. Andorfer Review 22 January 2010 Pages: 285 - 291
Combinatorial biomarker expression in breast cancer Emad A. RakhaJorge S. Reis-FilhoIan O. Ellis Review 28 January 2010 Pages: 293 - 308
Tai chi for breast cancer patients: a systematic review Myeong Soo LeeTae-Young ChoiEdzard Ernst Review 02 February 2010 Pages: 309 - 316
SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells Patrick MüllerJustin D. CroftsAnders Ström Preclinical study 26 March 2009 Pages: 317 - 326
Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines Ashok K. ChakrabortyAllison WelshMichael P. DiGiovanna Preclinical study 01 April 2009 Pages: 327 - 335
A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment Jue WangTian-Song XiaShui Wang Preclinical study 07 April 2009 Pages: 337 - 344
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery Evangelia-Ourania FourkalaCornelia Hauser-KronbergerMartin Widschwendter Preclinical study 08 April 2009 Pages: 345 - 355
Estrogen receptor α attenuates transforming growth factor-β signaling in breast cancer cells independent from agonistic and antagonistic ligands Matthias B. StopeSimone L. PoppMiriam B. Buck Preclinical study 16 April 2009 Pages: 357 - 367
Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor α in T47D breast cancer cells YenHao ChenKuangTzu HuangAmeae M. Walker Preclinical study 18 April 2009 Pages: 369 - 377
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model D. FuentesJ. AvellanetE. Montero Preclinical study 18 April 2009 Pages: 379 - 389
The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding Stefania MillevoiSandra BernatChristine Toulas Preclinical study 30 April 2009 Pages: 391 - 399
The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells Arend BrinkmanDanielle de JongLambert C. J. Dorssers Preclinical study 03 May 2009 Pages: 401 - 408
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma Jennifer DunlapClaudia LeMegan L. Troxell Preclinical study 06 May 2009 Pages: 409 - 418
Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor Cemal UlusoyIlknur KepenekciRagıp Cam Clinical trial 17 September 2009 Pages: 419 - 424
Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor Lisa A. Newman Invited Commentary 05 December 2009 Pages: 425 - 426
A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women T. CiglerD. TuP. E. Goss Clinical trial 06 December 2009 Pages: 427 - 435
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy Aditya BardiaVered Stearns Invited Commentary 17 February 2010 Pages: 437 - 439
Outcome of axillary staging in early breast cancer: a meta-analysis Malcolm R. KellJohn P. BurkeMonica Morrow Clinical trial 09 January 2010 Pages: 441 - 447
The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer Diane M. RenzJoachim BöttcherWerner A. Kaiser Clinical trial 20 January 2010 Pages: 449 - 459
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer Ruth E. BoardAndrew M. WardleyCaroline Dive Clinical trial 28 January 2010 Pages: 461 - 467
Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review Ying-Hua YuChi LiangXi-Zi Yuan Clinical Trial 04 February 2010 Pages: 469 - 479
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer Gottfried E. KonecnyGiovanni PaulettiDennis J. Slamon Clinical trial 04 February 2010 Pages: 481 - 489
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up Lisa RydénKarin JirströmMårten Fernö Clinical trial 05 February 2010 Pages: 491 - 498
Computer-aided detection in full-field digital mammography in a clinical population: performance of radiologist and technologists Frank J. H. M. van den BiggelaarAlphons G. H. KesselsKarin Flobbe Epidemiology 06 May 2009 Pages: 499 - 506
Comments on “Computer-aided detection in full-field digital mammography in a clinical population: performance of radiologist and technologists” Matthew T. Freedman Invited commentary 24 June 2009 Pages: 507 - 508
P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies Zhizhong ZhangMeilin WangZhengdong Zhang Epidemiology 23 July 2009 Pages: 509 - 517
Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva Christine BouchardyMassimo UselElisabetta Rapiti Epidemiology 25 July 2009 Pages: 519 - 523
